DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Infollion Research Services Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·22 Oct 2026, 7:20 am

Infollion Research Services

Infollion Research Services Limited has announced the availability of its transcript from a recent meeting with analysts and institutional investors. This document provides a detailed record of the discussions held during the event, offering insights into the company's current operations and future outlook.

For investors, this update is significant as it serves as an official source of information. It allows shareholders to review management's commentary on business performance and strategic plans, which can help in making more informed investment decisions.

Moving forward, market participants should focus on the specific details regarding revenue growth, operational efficiency, and guidance provided by the management in the transcript. This information will be crucial for assessing the company's trajectory in the coming quarters.